VRML : Summary for Vermillion, Inc. - Yahoo Finance

U.S. Markets close in 4 hrs 39 mins

Vermillion, Inc. (VRML)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.20+0.00 (+0.22%)
As of 10:36 AM EST. Market open.
People also watch:
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous Close1.20
Bid1.19 x 100
Ask1.20 x 900
Day's Range1.18 - 1.20
52 Week Range0.76 - 1.98
Avg. Volume53,003
Market Cap62.72M
PE Ratio (TTM)-3.61
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • PR Newswire21 days ago

    Vermillion Announces Appointment of Chief Medical Officer

    AUSTIN, Texas, Nov. 14, 2016 /PRNewswire/ -- Vermillion, Inc. (VRML), a bio-analytical solutions company today announced that Marra Francis, MD has been appointed to the position of Chief Medical Officer as of November 8th. Dr. Francis is a board certified Obstetrician and Gynecologist with over 13 years of clinical experience in both Private Practice and the Women's Health diagnostics industry. Dr. Francis' clinical practice over the years has ranged from general Obstetrician/Gynecologist to Gynecology only with a specialized focus on high risk cancer patients.

  • Vermillion, Inc. :VRML-US: Earnings Analysis: Q3, 2016 By the Numbers : November 14, 2016
    Capital Cube21 days ago

    Vermillion, Inc. :VRML-US: Earnings Analysis: Q3, 2016 By the Numbers : November 14, 2016

    Categories: Yahoo Finance Get free summary analysis Vermillion, Inc. reports financial results for the quarter ended September 30, 2016. We analyze the earnings along side the following peers of Vermillion, Inc. – OraSure Technologies, Inc., Quest Diagnostics Incorporated, Chembio Diagnostics, Inc., Foundation Medicine, Inc., Biocept, Inc., Quidel Corporation and Myriad Genetics, Inc. (OSUR-US, DGX-US, CEMI-US, FMI-US, BIOC-US, QDEL-US ... Read more (Read more...)

  • PR Newswire21 days ago

    Vermillion to Present Corporate Overview at the Canaccord Genuity Medical Technology and Diagnostic Forum

    AUSTIN, Texas, Nov. 14, 2016 /PRNewswire/ -- Vermillion, Inc. (NASDAQ: VRML), a bio-analytical solutions company focused on gynecologic disease, announced today that Valerie Palmieri, President and Chief ...